EGFP expressing virus
Infected xenografts 


Adenovirus CMV EGFP


Adenovirus IPPT EGFP


Baculovirus CMV EGFP

 

back to home page

A European Union funded collaborative project headed by Professor Norman Maitland, which aims to make gene therapy safer and acceptable for the treatment of prostate cancer.

  

 

Baculovirus capsids in PC3 (prostate cells) 8 hours post transduction


Red - Baculovirus attachment
Blue - Dapi stain, nucleus
Green - EGFP

European Commission Funded Research,
FP6-2002-LifeSciHealth
Contract No. LSHB-CT-2004-512087
Start 01/01/2005 to 31/12/2009


Coordinator:
Professor Norman J. Maitland
Director
YCR Cancer Research Unit (area 13)
Department of Biology
University of York,
York, UK, YO10 5YW

 

For all enquries about the website and GIANT project please contact:

Helen Evans
EU Technical Coordinator
YCR Cancer Research Unit (Area 13)
Department of Biology, University of York
Heslington, York, U.K.
YO10 5DD
T: +44 (0)1904 328709
F: +44 (0)1904 328710
E: biol-giant@york.ac.uk

 

Ellen Schenk-Braat (PhD), scientific manager
Erasmus MC, Department of Urology
Josephine Nefkens Institute, room Be362
Mailing address: PO Box 2040, 3000 CA Rotterdam
Street address: Dr. Molewaterplein 40, 3015 GD Rotterdam
The Netherlands
T: +44 (0)1904 328709
F: +44 (0)1904 328710
E: e.schenk-braat@erasmus.nl

GIANT home page